Cite
HARVARD Citation
Armoiry, X. et al. (2019). Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma. Journal of market access & health policy. 7 (1), p. . [Online].